UpcomingRegister in advance for each webinar

  • Thursday, August 13, 12-1330 EDT – IPSEN co-developedReal world evidence (ULISIII data and more) – Dr. Jorge Jacinto
  • Wednesday, September 9, 12-1330 EDT – IPSEN co-developed – Spasticity Patient Unmet Need (Carenity2 data & more) – Dr. Alberto Esquenazi
  • Thursday, September 17, 12-1330 EDT – Allergan co-developed – Toxin optimization & differentiation (Target audience Canada and AUS) – Rajiv Reebye (Optimization of Neurotoxins in Management of Spasticity) & Ted Wein (Clinical Review and Differentiation of Neurotoxins)
  • Thursday, September 24, 12-1330 EDT – Allergan co-developed – Early Intervention Traffic Light – Rajiv Reebye ( Early Identification and Early Intervention of PSS) & Paul Winston ( Referral Pathway and the PSS Risk Classification System Tool utilization in Clinical Practice)  
  • TBD Thierry Deltombe – Approach to the complex spastic lower limb with neurotomy and neurectomy. (The spastic foot management: the Mont-Godinne guidance or The neurotomy as a treatment of focal spasticity or Should we modify our treatment according to the type of spastic muscle overactivity?)